JP2002523518A5 - - Google Patents

Download PDF

Info

Publication number
JP2002523518A5
JP2002523518A5 JP2000567569A JP2000567569A JP2002523518A5 JP 2002523518 A5 JP2002523518 A5 JP 2002523518A5 JP 2000567569 A JP2000567569 A JP 2000567569A JP 2000567569 A JP2000567569 A JP 2000567569A JP 2002523518 A5 JP2002523518 A5 JP 2002523518A5
Authority
JP
Japan
Prior art keywords
peptide
amino acid
acid
hydrophobic amino
peptide according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000567569A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002523518A (ja
JP4528443B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/019378 external-priority patent/WO2000012553A1/en
Publication of JP2002523518A publication Critical patent/JP2002523518A/ja
Publication of JP2002523518A5 publication Critical patent/JP2002523518A5/ja
Application granted granted Critical
Publication of JP4528443B2 publication Critical patent/JP4528443B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000567569A 1998-08-28 1999-08-20 環状プロサポシン由来のペプチドおよびその使用 Expired - Fee Related JP4528443B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9835998P 1998-08-28 1998-08-28
US60/098,359 1998-08-28
PCT/US1999/019378 WO2000012553A1 (en) 1998-08-28 1999-08-20 Cyclic prosaposin-derived peptides and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010034833A Division JP2010150272A (ja) 1998-08-28 2010-02-19 環状プロサポシン由来のペプチドおよびその使用

Publications (3)

Publication Number Publication Date
JP2002523518A JP2002523518A (ja) 2002-07-30
JP2002523518A5 true JP2002523518A5 (https=) 2006-08-10
JP4528443B2 JP4528443B2 (ja) 2010-08-18

Family

ID=22268937

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000567569A Expired - Fee Related JP4528443B2 (ja) 1998-08-28 1999-08-20 環状プロサポシン由来のペプチドおよびその使用
JP2010034833A Pending JP2010150272A (ja) 1998-08-28 2010-02-19 環状プロサポシン由来のペプチドおよびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010034833A Pending JP2010150272A (ja) 1998-08-28 2010-02-19 環状プロサポシン由来のペプチドおよびその使用

Country Status (13)

Country Link
EP (1) EP1105420A1 (https=)
JP (2) JP4528443B2 (https=)
KR (1) KR20010079695A (https=)
CN (1) CN1324367A (https=)
AU (1) AU751034B2 (https=)
BR (1) BR9913490A (https=)
CA (1) CA2341810A1 (https=)
CZ (1) CZ2001655A3 (https=)
HU (1) HUP0103265A3 (https=)
IL (1) IL141586A0 (https=)
PL (1) PL204359B1 (https=)
WO (1) WO2000012553A1 (https=)
ZA (1) ZA200102489B (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
PL204359B1 (pl) * 1998-08-28 2010-01-29 Myelos Corp Cykliczne peptydy, zawierająca je kompozycja farmaceutyczna i ich zastosowania
AUPQ084899A0 (en) * 1999-06-08 1999-07-01 University Of Melbourne, The Neurotrophin agonists
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide
CN100366286C (zh) * 2003-04-28 2008-02-06 常州南云科技有限公司 Saposin C-DOPS:一种抗癌新药
EP2020988B1 (en) 2006-04-28 2017-08-16 Children's Hospital Medical Center Compositions comprising fusogenic proteins or polypeptides derived from prosaposin for application in transmembrane drug delivery systems
JP5253402B2 (ja) * 2006-10-20 2013-07-31 チルドレンズ ホスピタル メディカル センター 自発的に形成する楕円体の単層リン脂質小胞
CN103275187B (zh) * 2013-06-14 2014-10-29 四川合泰新光生物科技有限公司 一种镇痛肽fi及其基因和应用
CN107530257B (zh) 2015-04-23 2022-03-29 宝洁公司 表面活性剂可溶性去头皮屑剂的递送
ES2893974T3 (es) 2016-03-03 2022-02-10 Procter & Gamble Composición anticaspa en aerosol
US11154467B2 (en) 2016-10-21 2021-10-26 The Procter And Gamble Plaza Concentrated shampoo dosage of foam designating hair conditioning benefits
EP3528897A1 (en) 2016-10-21 2019-08-28 The Procter & Gamble Company Dosage of foam for delivering consumer desired dosage volume, surfactant amount, and scalp health agent amount in an optimal formulation space
US11141361B2 (en) 2016-10-21 2021-10-12 The Procter And Gamble Plaza Concentrated shampoo dosage of foam designating hair volume benefits
WO2018075836A1 (en) 2016-10-21 2018-04-26 The Procter & Gamble Company Concentrated shampoo dosage of foam for providing hair care benefits
WO2018075841A1 (en) 2016-10-21 2018-04-26 The Procter & Gamble Company Concentrated shampoo dosage of foam for providing hair care benefits
CN109862944A (zh) 2016-10-21 2019-06-07 宝洁公司 用于以最佳制剂空间递送消费者所需的剂型体积和表面活性剂量的泡沫剂型
MX386123B (es) 2016-10-21 2025-03-18 Procter & Gamble Productos de champú compactos y estables con baja viscosidad y agente reductor de viscosidad.
US11141370B2 (en) 2017-06-06 2021-10-12 The Procter And Gamble Company Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel
US11224567B2 (en) 2017-06-06 2022-01-18 The Procter And Gamble Company Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel
US11679073B2 (en) 2017-06-06 2023-06-20 The Procter & Gamble Company Hair compositions providing improved in-use wet feel
US11607373B2 (en) 2017-10-10 2023-03-21 The Procter & Gamble Company Sulfate free clear personal cleansing composition comprising low inorganic salt
WO2019074988A1 (en) 2017-10-10 2019-04-18 The Procter & Gamble Company METHOD OF TREATING HAIR OR SKIN WITH PERSONAL FOAM COMPOSITION IN THE FORM OF FOAM
MX388495B (es) 2017-10-10 2025-03-20 Procter & Gamble Composición de champú compacto que contiene surfactantes libres de sulfato.
JP2020536876A (ja) 2017-10-10 2020-12-17 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company アミノ酸系アニオン性界面活性剤及びカチオン性ポリマーを含むコンパクトシャンプー組成物
JP7280265B2 (ja) 2017-12-20 2023-05-23 ザ プロクター アンド ギャンブル カンパニー シリコーンポリマーを含有する透明なシャンプー組成物
MX2020014144A (es) 2018-06-29 2021-03-25 Procter & Gamble Composicion anticaspa en aerosol con bajo contenido de surfactante.
US12226505B2 (en) 2018-10-25 2025-02-18 The Procter & Gamble Company Compositions having enhanced deposition of surfactant-soluble anti-dandruff agents
JP7410298B2 (ja) 2019-12-06 2024-01-09 ザ プロクター アンド ギャンブル カンパニー 頭皮活性物質の付着を強化する硫酸塩を含まない組成物
MX2022009191A (es) 2020-02-27 2022-08-18 Procter & Gamble Composiciones anticaspa con azufre que tienen eficacia y estetica mejoradas.
JP7678101B2 (ja) 2020-11-23 2025-05-15 ザ プロクター アンド ギャンブル カンパニー 硫酸化界面活性剤を含まないパーソナルケア組成物
US11819474B2 (en) 2020-12-04 2023-11-21 The Procter & Gamble Company Hair care compositions comprising malodor reduction materials
US12409125B2 (en) 2021-05-14 2025-09-09 The Procter & Gamble Company Shampoo compositions containing a sulfate-free surfactant system and sclerotium gum thickener
US11986543B2 (en) 2021-06-01 2024-05-21 The Procter & Gamble Company Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants
JP2024544222A (ja) 2021-12-09 2024-11-28 ザ プロクター アンド ギャンブル カンパニー 有効な防腐性を備えるサルフェート不含有パーソナルクレンジング組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL106106A0 (en) * 1993-06-22 1993-10-20 Interpharm Lab Ltd Library of polymeric molecules and its preparation
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
PL204359B1 (pl) * 1998-08-28 2010-01-29 Myelos Corp Cykliczne peptydy, zawierająca je kompozycja farmaceutyczna i ich zastosowania

Similar Documents

Publication Publication Date Title
JP2002523518A5 (https=)
JP3266311B2 (ja) 新規ポリペプチドおよびこれを用いる抗hiv剤
JP4192114B2 (ja) 環式付着阻害剤
AU714846B2 (en) Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
US5854211A (en) Compounds with growth hormone releasing properties
US5470828A (en) Peptide analogs of insulin-like growth factor II
CA2308116A1 (en) Low-toxicity human interferon-alpha analog
ATE206716T1 (de) Cyclische wirkstoff-vorläufer verbindungen von peptiden und peptid-nukleicsäuren mit verbesserter metabolischer stabilität und zellmembran permeabilität
EP1025840A3 (en) Oral drug compositions and methods
US4603120A (en) Cyclic octapeptides and pharmaceutical preparations thereof, as well as processes for their manufacture, and their use
JP2002524393A5 (https=)
DE69227462D1 (de) Peptide mit wachstumshormonfreisetzender aktivität
CA2332817A1 (en) Il-6 antagonist peptides
JP2004531242A5 (https=)
JPH0273100A (ja) 医薬用化合物
RU2000109265A (ru) Лечение ожирения
CA2311648A1 (en) Ifnar2/ifn complex
KR927002373A (ko) 성장 호르몬 분비 활성을 갖는 폴리펩타이드 화합물
HUT77979A (hu) Peptidek, előállításuk és ezeket tartalmazó gyógyszerkészítmények
ITMI952681A1 (it) Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita
DE60133654D1 (de) Arzneimittel enthaltend analgetische peptide
RU2004104335A (ru) Биологически активные пептиды
US5807985A (en) Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone
CA2465667A1 (en) New peptides - analogs of human growth hormone-releasing hormone
JPS62228099A (ja) 新規なゴナドリベリン誘導体